Duncan Mchale - Net Worth and Insider Trading
Duncan Mchale Net Worth
The estimated net worth of Duncan Mchale is at least $8 dollars as of 2025-01-13. Duncan Mchale is the Chief Medical Officer of Evelo Biosciences Inc and owns about 16,984 shares of Evelo Biosciences Inc (EVLO) stock worth over $8. Details can be seen in Duncan Mchale's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Duncan Mchale has not made any transactions after 2023-11-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Duncan Mchale
Duncan Mchale Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Duncan Mchale owns 1 companies in total, including Evelo Biosciences Inc (EVLO) .
Click here to see the complete history of Duncan Mchale’s form 4 insider trades.
Insider Ownership Summary of Duncan Mchale
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EVLO | Evelo Biosciences Inc | 2023-11-08 | Chief Medical Officer |
Duncan Mchale Latest Holdings Summary
Duncan Mchale currently owns a total of 1 stock. Duncan Mchale owns 16,984 shares of Evelo Biosciences Inc (EVLO) as of November 8, 2023, with a value of $8.
Latest Holdings of Duncan Mchale
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EVLO | Evelo Biosciences Inc | 2023-11-08 | 16,984 | 0.00 | 8 |
Holding Weightings of Duncan Mchale
Duncan Mchale Form 4 Trading Tracker
According to the SEC Form 4 filings, Duncan Mchale has made a total of 5 transactions in Evelo Biosciences Inc (EVLO) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Evelo Biosciences Inc is the sale of 3,103 shares on November 8, 2023, which brought Duncan Mchale around $1,024.
Insider Trading History of Duncan Mchale
- 1
Duncan Mchale Trading Performance
GuruFocus tracks the stock performance after each of Duncan Mchale's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Duncan Mchale is 0.47%. GuruFocus also compares Duncan Mchale's trading performance to market benchmark return within the same time period. The performance of stocks bought by Duncan Mchale within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Duncan Mchale's insider trading performs compared to the benchmark.
Performance of Duncan Mchale
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.72 | | | | | |
| Relative Return to S&P 500(%) | 10.93 | | | | | |
Duncan Mchale Ownership Network
Ownership Network List of Duncan Mchale
Ownership Network Relation of Duncan Mchale
Duncan Mchale Owned Company Details
What does Evelo Biosciences Inc do?
Who are the key executives at Evelo Biosciences Inc?
Duncan Mchale is the Chief Medical Officer of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include See Remarks Mark Bodmer , Chief Financial Officer Marella Thorell , and director & President & CEO Simba Gill .
Evelo Biosciences Inc (EVLO) Insider Trades Summary
Over the past 18 months, Duncan Mchale made 3 insider transaction in Evelo Biosciences Inc (EVLO) with a net sale of 13,391. Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 13,145 shares made by Mark Bodmer , a net sale of 7,814 shares made by Marella Thorell , and a net sale of 2,510 shares made by Simba Gill .
In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,860 shares of Evelo Biosciences Inc (EVLO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 36,860 shares.
Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evelo Biosciences Inc Insider Transactions
Duncan Mchale Mailing Address
Above is the net worth, insider trading, and ownership report for Duncan Mchale. You might contact Duncan Mchale via mailing address: C/o Evelo Biosciences, Inc., 620 Memorial Drive, Suite 200, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
